Cargando…
What is the relationship between bone turnover markers and skeletal-related events in patients with bone metastases from solid tumors and in patients with multiple myeloma? A systematic review and meta-regression analysis
INTRODUCTION: As a result of the negative impact of bone metastases on patient quality of life, it is important to identify patients at increased risk of skeletal-related events (SREs). Biochemical markers produced by osteoblasts and osteoclasts may provide an early indicator of treatment response t...
Autores principales: | Jiang, Zefei, Tang, En-Tzu, Li, Chuang, Zhu, Li, Zhang, Biao, Glennane, Tony, Zhang, Li |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7215099/ https://www.ncbi.nlm.nih.gov/pubmed/32420416 http://dx.doi.org/10.1016/j.bonr.2020.100272 |
Ejemplares similares
-
Markers of bone turnover for the management of patients with bone metastases from prostate cancer
por: Garnero, P, et al.
Publicado: (2000) -
Role of denosumab in the management of skeletal complications in patients with bone metastases from solid tumors
por: Brown-Glaberman, Ursa, et al.
Publicado: (2012) -
Cost analysis of skeletal-related events in Spanish patients with bone metastases from solid tumours
por: Durán, I., et al.
Publicado: (2013) -
Skeletal morbidity rates over time in patients with bone metastases from solid tumors reported in bone modifying agents randomised trials
por: Poon, Michael, et al.
Publicado: (2012) -
Biochemical evaluation of bone turnover in cancer patients with bone metastases: relationship with radiograph appearances and disease extension.
por: Berruti, A., et al.
Publicado: (1996)